Somatostatin (sst) Receptors
Somatostatin (somatotropin release inhibiting factor, SRIF) is an endogenous cyclic polypeptide with two biologically active forms. It is an abundant neuropeptide and has a wide range of physiological effects on neurotransmission, secretion and cell proliferation.
Somatostatin (sst) Receptor Agonists |
|
---|---|
Cat. No. | Product Name / Activity |
6201 | J 2156 |
Selective high affinity human sst4 agonist | |
1980 | L-817,818 |
Potent and selective sst5 agonist | |
2440 | NNC 26-9100 |
Selective sst4 agonist | |
1818 | Octreotide |
sst2, sst3 and sst5 agonist | |
1157 | Somatostatin |
Influences growth hormone release | |
1165 | Somatostatin 1-28 |
sst agonist | |
Somatostatin (sst) Receptor Antagonists |
|
Cat. No. | Product Name / Activity |
3493 | Cyclosomatostatin |
Non-selective sst antagonist | |
1843 | CYN 154806 |
Selective sst2 antagonist | |
Other |
|
Cat. No. | Product Name / Activity |
3374 | Cortistatin 14 |
Endogenous neuropeptide; binds sst1 - sst5, ghrelin receptor and MRGPRX2 |
Somatostatin (somatotropin release inhibiting factor, SRIF) is an endogenous cyclic polypeptide with two biologically active forms. It is an abundant neuropeptide and has a wide range of physiological effects on neurotransmission, secretion and cell proliferation. The somatostatin receptor family consists of five subtypes, sst1-5, each differentially distributed throughout the central nervous system and periphery. Endogenous somatostatin receptor ligands include somatostatin-14 and somatostatin-28.
Somatostatin receptors have diverse biological functions due to their varied distribution and the fact that they couple to different second messengers - namely adenylyl cyclase, PLC, K+ channels and Ca2+ channels, amongst others.
Somatostatin receptors in the hypothalamus are involved in the regulation of growth hormone secretion. Other hormones regulated by somatostatin receptors include thyrotropin and prolactin. Somatostatin has antiproliferative effects via stimulation of protein tyrosine phosphatase activity and of the MAPK signaling cascade, with subsequent induction of G1 cell cycle arrest (sst1, sst4, sst5) and promotion of apoptosis (sst2, sst3). It also exhibits antiangiogenic activity via activation of sst3. Somatostatin regulates neuronal activity by regulating AMPA/kainate-mediated responses to glutamate. Different sst subtypes have opposing effects in this system.
Somatostatin receptors also play a role in blood glucose homeostasis; sst5 receptors in the pancreatic β-cells stimulate insulin secretion, whilst sst2 receptors are involved in glucagon secretion from α-cells. In addition, sst2 receptors inhibit gastric acid secretion and peristalsis in the jejunum. Somatostatin suppresses the release of numerous gastrointestinal hormones, including gastrin, cholecystokinin, secretin and VIP, and consequently plays an integral role in gastrointestinal endocrinology.
External sources of pharmacological information for Somatostatin (sst) Receptors :
Somatostatin Receptor Gene Data
Gene | Species | Gene Symbol | Gene Accession No. | Protein Accession No. |
---|---|---|---|---|
sst1 | Human | SSTR1 | NM_001049 | P30872 |
Mouse | Sstr1 | NM_009216 | P30873 | |
Rat | Sstr1 | NM_012719 | P28646 | |
sst2 | Human | SSTR2 | NM_001050 | P30874 |
Mouse | Sstr2 | NM_001042606 | P30875 | |
Rat | Sstr2 | NM_019348 | P30680 | |
sst3 | Human | SSTR3 | NM_001051 | P32745 |
Mouse | Sstr3 | NM_009218 | P30935 | |
Rat | Sstr3 | NM_133522 | P30936 | |
sst4 | Human | SSTR4 | NM_001052 | P31391 |
Mouse | Sstr4 | NM_009219 | P49660 | |
Rat | Sstr4 | NM_031547 | P08485 | |
sst5 | Human | SSTR5 | NM_001053 | P35346 |
Mouse | Sstr5 | NM_011425 | O08858 | |
Rat | Sstr5 | NM_012882 | P30938 |
Somatostatin Receptor Data
Receptor Subtype | sst1 | sst2 | sst3 | sst4 | sst5 | |
---|---|---|---|---|---|---|
Transduction Mechanism | Gi | Gi | Gi | Gi | Gi | |
Primary Distribution | Stomach, jejunum, pituitary | Cerebrum, kidney, pituitary | Cerebrum, pituitary, pancreas | Cortex, hypothalamus, lung | Pituitary, hypothalamus, small intestine | |
Key Compounds | Ki/IC50 (nM) | |||||
Agonists |
BIM 23052 (2842) L-803,087 (1979) L-817,818 (1980) Octreotide (1818) RC 160 (3139) Seglitide (1836) Somatostatin (1157) Somatostatin 1-28 (1165) |
31.3 199 3.3 > 1000 > 1000 > 1000 1.1 2.2 |
13.5 4720 52 2.1 5.4 1.5 1.3 4.1 - |
- 1280 64 4.4 30.9 27 1.6 6.1 |
141 82 0.7 > 1000 45 127 0.53 1.1 |
7.3 3880 0.4 5.6 0.7 2 0.9 0.07 |
Antagonists |
BIM 23056 (1844) CYN 154806 (1843) |
142 5.41* |
> 1000 8.85* |
10.8 6.07* |
16.6 5.76* |
5.7 6.48* |
* pIC50 values
References
Moller et al (2003) Somatostatin Receptors. Biochem.Biophys.Acta. 1616 1. Alexander et al (2004) Guide to receptors and channels. Br.J.Pharmacol. 141 Suppl.1. Patel and Srikant (1995) Subtype selectivity of peptide analogues for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135 2814. Fenuik et al (2000) Selective somatostatin sst2 receptor blockade with the novel cyclic octapeptide, CYN-154806. Neuropharmacology 39 1443. Rohrer and Schaeffer (2000) Identification and characterization of subtype selective somatostatin receptor agonists. J.Physiol. 94 211.